Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 11, 2020

ImmunoGen, Inc. v. Iancu

Track this case

Case Number:

1:20-cv-00274

Court:

Virginia Eastern

Nature of Suit:

Patent

Judge:

T. S. Ellis, III

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 31, 2023

    ImmunoGen Loses Trial Bid To Secure Cancer Therapy Patent

    A Virginia federal judge issued a bench trial ruling Monday that ImmunoGen is not entitled to a patent on a cancer treatment, rejecting the company's claims for a second time after the Federal Circuit vacated the court's previous decision and ordered a trial.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login